Developer docs
API playgroundTry for free, no card

Search company profiles

DaVinci

Full company profile

uuid002h6ef

Namestring
DaVinci
Legal namestring
DaVINCI Biomedical Research
Company typeenum
Private
Founded yearint
1994
Descriptiontext

DaVinci (operating as DaVinci Biomedical Research) is a private, for-profit preclinical contract research organization (CRO) founded in 1993 and headquartered in Central Massachusetts. The company operates a 67,000+ sq ft state-of-the-art, AAALAC-accredited facility and provides both GLP and non-GLP in vivo preclinical testing services to sponsors in the medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine sectors. Core service offerings include telemetry, biomechanical testing, custom model development, and pre-instrumentation of animal models — capabilities typically required for IND- and IDE-enabling safety, efficacy, and feasibility studies.

Underlying technical capabilities center on surgical execution and vivarium-based in vivo study execution, with AAALAC accreditation and GLP compliance serving as regulatory-grade quality infrastructure that sponsors require for regulatory submission data. The company's business model is fee-for-service CRO work, monetizing through study-based contracts where pricing scales with model complexity, study duration, GLP vs. non-GLP tier, telemetry/biomechanical instrumentation, and custom model development scope. Customer segments span medtech, pharma, biotech, and advanced therapy sponsors, giving the company diversified exposure across preclinical end-markets rather than dependency on a single sponsor type.

The 30+ year operating history and breadth of vertical coverage suggest an established niche CRO with multi-decadal sponsor relationships, though the publicly available material is thin on recent capacity additions, hiring signals, or technology investments that would indicate the company's current operating momentum.

Short descriptiontext

DaVinci Biomedical Research is a Central Massachusetts-based preclinical CRO operating a 67,000+ sq ft AAALAC-accredited facility, delivering GLP and non-GLP in vivo testing, telemetry, biomechanical, and custom model development services to medical device, pharma, biotech, gene therapy, and regenerative medicine sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWorcester, United States
HQ citystring
Worcester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical CRO services, GLP animal testing, medical device testing, in vivo research, pharmaceutical preclinical studies
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical CRO Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Preclinical Contract Research Services
TypeProfessional Services
Description

Contract research organization (CRO) providing fee-for-service preclinical testing including GLP studies for FDA submissions, non-GLP developmental studies, acute and chronic testing across multiple therapeutic areas. Revenue generated through project-based contracts for medical device testing, pharmaceutical research, gene therapy validation, and regenerative medicine studies.

davincibiomed.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DaVINCI Biomedical Research is a preclinical Contract Research Organization (CRO) providing GLP and non-GLP in vivo animal testing services for medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine companies. Core offerings include customized preclinical model development, pre-instrumentation of models, in vivo surgical testing, biocompatibility/toxicology/pyrogenicity evaluations, and efficacy and safety studies that support FDA regulatory submissions (510K and IND). All services are delivered from an AAALAC-accredited, 67,000+ sq. ft. facility in Central Massachusetts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reliable and reproducible results for safety and efficacy studies
Product overview1 text field

DaVINCI Biomedical Research is a premier preclinical CRO offering a unified platform of integrated testing services. The portfolio centers on GLP and non-GLP preclinical testing services for medical devices, pharmaceuticals, biotechnology, and gene therapy sectors. Core offerings include In Vivo Testing with specialized surgical models, Medical Device Testing with telemetry and biomechanical capabilities, Pharmaceutical Research covering pharmacokinetics and toxicology, Gene Therapy Solutions, Biotechnology Research Services, and Regenerative Medicine studies. All services support FDA regulatory submissions (510K, IND) and span therapeutic areas including cardiovascular, neurological, orthopedic, gastrointestinal, and wound healing applications.

Product and service9 records
1Preclinical Testing Services
CategoryPreclinical Contract Research
Description

Premier preclinical CRO offering GLP and non-GLP animal studies for medical devices, pharmaceuticals, biotechnology, and gene therapy applications. Services include biocompatibility testing, toxicology, pyrogenicity, safety and efficacy studies, and acute-chronic testing.

2In Vivo Testing
CategoryPreclinical Contract Research
Description

In vivo animal model testing services with specialized surgical expertise for cardiovascular, neurological, orthopedic, gastrointestinal, and other applications, supporting acute and chronic study designs.

3GLP Studies for FDA Submission
CategoryRegulatory Preclinical Testing
Description

Good Laboratory Practice compliant studies designed for FDA regulatory submissions including 510K, IND, safety, efficacy, and biocompatibility evaluations.

4Non-GLP Developmental Studies
CategoryPreclinical Contract Research
Description

Flexible non-GLP research studies for drug and device development at various stages of the research pipeline.

5Medical Device Testing
CategoryMedical Device Preclinical Testing
Description

Comprehensive medical device preclinical testing including cardiovascular, endovascular, neurological, orthopedic, gastrointestinal, wound healing, meshes, and coatings testing with telemetry solutions and biomechanical testing capabilities.

6Biotechnology Research Services
CategoryBiotechnology Preclinical Research
Description

Preclinical research services supporting biotech companies with precision and scientific rigor for groundbreaking discoveries across multiple disciplines including siRNA, Engineered Cells, Small Molecule, Nano Treatments, Bio-printed and Bio-generated Materials, and Engineered Tissues.

7Gene Therapy Solutions
CategoryGene Therapy Preclinical Research
Description

Expertise in gene therapy research including cellular, vectors (bacterial and viral), nanoparticles, and gene editing applications.

8Pharmaceutical Research
CategoryPharmaceutical Preclinical Testing
Description

Pharmaceutical testing services covering pharmacokinetics, toxicokinetic, biodistribution, PK characterization, metabolization, and interspecies scaling across multiple disciplines.

9Regenerative Medicine
CategoryRegenerative Medicine Preclinical Testing
Description

Regenerative medicine research including organ scaffold and cell-based solutions, cardiovascular medicine, orthopedics, urology, organ/tissue transplant, soft and connective tissue therapies, wound healing, and bone regeneration.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DaVinci

Preclinical CRO Servicesdavincibiomed.com

DaVinci Biomedical Research is a Central Massachusetts-based preclinical CRO operating a 67,000+ sq ft AAALAC-accredited facility, delivering GLP and non-GLP in vivo testing, telemetry, biomechanical, and custom model development services to medical device, pharma, biotech, gene therapy, and regenerative medicine sponsors.

What DaVinci does

DaVinci (operating as DaVinci Biomedical Research) is a private, for-profit preclinical contract research organization (CRO) founded in 1993 and headquartered in Central Massachusetts. The company operates a 67,000+ sq ft state-of-the-art, AAALAC-accredited facility and provides both GLP and non-GLP in vivo preclinical testing services to sponsors in the medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine sectors. Core service offerings include telemetry, biomechanical testing, custom model development, and pre-instrumentation of animal models — capabilities typically required for IND- and IDE-enabling safety, efficacy, and feasibility studies.

Underlying technical capabilities center on surgical execution and vivarium-based in vivo study execution, with AAALAC accreditation and GLP compliance serving as regulatory-grade quality infrastructure that sponsors require for regulatory submission data. The company's business model is fee-for-service CRO work, monetizing through study-based contracts where pricing scales with model complexity, study duration, GLP vs. non-GLP tier, telemetry/biomechanical instrumentation, and custom model development scope. Customer segments span medtech, pharma, biotech, and advanced therapy sponsors, giving the company diversified exposure across preclinical end-markets rather than dependency on a single sponsor type.

The 30+ year operating history and breadth of vertical coverage suggest an established niche CRO with multi-decadal sponsor relationships, though the publicly available material is thin on recent capacity additions, hiring signals, or technology investments that would indicate the company's current operating momentum.

DaVinci firmographics

Firmographics
Name
DaVinci
Legal name
DaVINCI Biomedical Research
Website
https://davincibiomed.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
DaVinci Biomedical Research is a Central Massachusetts-based preclinical CRO operating a 67,000+ sq ft AAALAC-accredited facility, delivering GLP and non-GLP in vivo testing, telemetry, biomechanical, and custom model development services to medical device, pharma, biotech, gene therapy, and regenerative medicine sponsors.
Ownership category
akta.pro rank

Where DaVinci is headquartered

Location

Headquarters

HQ city
Worcester
HQ country
United States
HQ region
North America

Offices1 record

Markets served

DaVinci business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Preclinical Contract Research Services: Contract research organization (CRO) providing fee-for-service preclinical testing including GLP studies for FDA submissions, non-GLP developmental studies, acute and chronic testing across multiple therapeutic areas. Revenue generated through project-based contracts for medical device testing, pharmaceutical research, gene therapy validation, and regenerative medicine studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

DaVinci product offering

Product offering

Core offering

DaVINCI Biomedical Research is a preclinical Contract Research Organization (CRO) providing GLP and non-GLP in vivo animal testing services for medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine companies. Core offerings include customized preclinical model development, pre-instrumentation of models, in vivo surgical testing, biocompatibility/toxicology/pyrogenicity evaluations, and efficacy and safety studies that support FDA regulatory submissions (510K and IND). All services are delivered from an AAALAC-accredited, 67,000+ sq. ft. facility in Central Massachusetts.

Product overview

DaVINCI Biomedical Research is a premier preclinical CRO offering a unified platform of integrated testing services. The portfolio centers on GLP and non-GLP preclinical testing services for medical devices, pharmaceuticals, biotechnology, and gene therapy sectors. Core offerings include In Vivo Testing with specialized surgical models, Medical Device Testing with telemetry and biomechanical capabilities, Pharmaceutical Research covering pharmacokinetics and toxicology, Gene Therapy Solutions, Biotechnology Research Services, and Regenerative Medicine studies. All services support FDA regulatory submissions (510K, IND) and span therapeutic areas including cardiovascular, neurological, orthopedic, gastrointestinal, and wound healing applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Preclinical Testing Services Premier preclinical CRO offering GLP and non-GLP animal studies for medical devices, pharmaceuticals, biotechnology, and gene therapy applications. Services include biocompatibility testing, toxicology, pyrogenicity, safety and efficacy studies, and acute-chronic testing.
  • In Vivo Testing In vivo animal model testing services with specialized surgical expertise for cardiovascular, neurological, orthopedic, gastrointestinal, and other applications, supporting acute and chronic study designs.
  • GLP Studies for FDA Submission Good Laboratory Practice compliant studies designed for FDA regulatory submissions including 510K, IND, safety, efficacy, and biocompatibility evaluations.
  • Non-GLP Developmental Studies Flexible non-GLP research studies for drug and device development at various stages of the research pipeline.
  • Medical Device Testing Comprehensive medical device preclinical testing including cardiovascular, endovascular, neurological, orthopedic, gastrointestinal, wound healing, meshes, and coatings testing with telemetry solutions and biomechanical testing capabilities.
  • Biotechnology Research Services Preclinical research services supporting biotech companies with precision and scientific rigor for groundbreaking discoveries across multiple disciplines including siRNA, Engineered Cells, Small Molecule, Nano Treatments, Bio-printed and Bio-generated Materials, and Engineered Tissues.
  • Gene Therapy Solutions Expertise in gene therapy research including cellular, vectors (bacterial and viral), nanoparticles, and gene editing applications.
  • Pharmaceutical Research Pharmaceutical testing services covering pharmacokinetics, toxicokinetic, biodistribution, PK characterization, metabolization, and interspecies scaling across multiple disciplines.
  • Regenerative Medicine Regenerative medicine research including organ scaffold and cell-based solutions, cardiovascular medicine, orthopedics, urology, organ/tissue transplant, soft and connective tissue therapies, wound healing, and bone regeneration.

Quantifiable outcome

  • Reliable and reproducible results for safety and efficacy studies

Companies that use DaVinci

Customer profile

Segments5 records

Ideal customer profiles5 records

DaVinci technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

DaVinci partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

DaVinci competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

DaVinci compliance and trust

Trust signal

Compliance3 records

DaVinci financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DaVinci leadership team

Management profile

Number of profiles

Profiles1 record

DaVinci funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DaVinci M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DaVinci

What does DaVinci do?

DaVINCI Biomedical Research is a preclinical Contract Research Organization (CRO) providing GLP and non-GLP in vivo animal testing services for medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine companies. Core offerings include customized preclinical model development, pre-instrumentation of models, in vivo surgical testing, biocompatibility/toxicology/pyrogenicity evaluations, and efficacy and safety studies that support FDA regulatory submissions (510K and IND). All services are delivered from an AAALAC-accredited, 67,000+ sq. ft. facility in Central Massachusetts.

Is DaVinci a public or private company?

DaVinci is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DaVinci founded?

DaVinci was founded in 1994. It employs 11 to 50 people.

Where is DaVinci based?

DaVinci is headquartered in Worcester, United States, in the North America region.

How does DaVinci make money?

One revenue line is on record: preclinical Contract Research Services.

Does DaVinci have an API?

No public API is recorded for DaVinci.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales